Invention Grant
- Patent Title: Antibody-drug conjugates comprising a cyclic dinucleotide
-
Application No.: US17065242Application Date: 2020-10-07
-
Publication No.: US11666594B2Publication Date: 2023-06-06
- Inventor: Masato Yoshikawa , Morihisa Saitoh , Taisuke Kato , Yayoi Nakayama , Tomohiro Seki , Yasuo Nakagawa , Yusuke Tominari , Masaki Seto , Yusuke Sasaki , Masanori Okaniwa , Tsuneo Oda , Akito Shibuya , Kosuke Hidaka , Zenyu Shiokawa , Shumpei Murata , Atsutoshi Okabe , Yoshihisa Nakada , Michiyo Mochizuki , Brian Scott Freeze , Taisuke Tawaraishi , Yasufumi Wada , Paul D. Greenspan
- Applicant: TAKEDA PHARMACEUTICAL COMPANY LIMITED
- Applicant Address: JP Osaka
- Assignee: Takeda Pharmaceutical Company Limited
- Current Assignee: Takeda Pharmaceutical Company Limited
- Current Assignee Address: JP Osaka
- Agency: Sterne, Kessler, Goldstein & Fox P.L.L.C.
- Priority: JP 16234553 2016.12.01 JP 17107216 2017.05.30
- The original application number of the division: US16185258 2018.11.09
- Main IPC: A61K31/7084
- IPC: A61K31/7084 ; A61P35/00 ; C07H21/00 ; C07H21/02 ; A61K47/68 ; A61K31/7076
Abstract:
The present disclosure provides a compound having a STING agonistic activity, which may be expected to be useful as an agent for the prophylaxis or treatment of STING-related diseases.
The present disclosure relates to a compound represented by the formula (I):
wherein each symbol is as defined in the description, or a salt thereof.
The present disclosure relates to a compound represented by the formula (I):
wherein each symbol is as defined in the description, or a salt thereof.
Public/Granted literature
- US20210106607A1 ANTIBODY-DRUG CONJUGATES COMPRISING A CYCLIC DINUCLEOTIDE Public/Granted day:2021-04-15
Information query
